首页> 外国专利> RELEASE OF EXTRACELLULAR MEMBRANE PARTICLES CARRYING THE STEM CELL MARKER PROMININ-1 (CD133) FROM NEURAL PROGENITORS AND OTHER EPITHELIAL CELLS

RELEASE OF EXTRACELLULAR MEMBRANE PARTICLES CARRYING THE STEM CELL MARKER PROMININ-1 (CD133) FROM NEURAL PROGENITORS AND OTHER EPITHELIAL CELLS

机译:从神经祖细胞和其他上皮细胞释放携带干细胞标志物PROMININ-1(CD133)的细胞外膜颗粒

摘要

The present invention relates to an extracellular membrane particle carrying integrated into the membrane prominin-1 molecules. In accordance with the present invention, theses particles also referred to as prominin-1 -containing membrane particles. The membrane particles according to the present invention are distinct from exosomes. The invention in a further aspect relates to a method of diagnosing an epithelial cancer or a hematopoietic disease in a mammal comprising assessing in a body fluid of said mammal for the presence of the extracellular membrane particle of the invention wherein a decreased level of said extracellular membrane particles as compared to a control value is indicative of the presence of an epithelial cancer or a hematopoietic disease. Alternatively, an increased level of said particles is indicative of the presence of such a disease in a mammal. Additionally, the present invention relates to a method of prognosing a solid tumor in a mammal, comprising determining the change in the number of the particles of the invention in a body fluid of said mammal over time. Finally, the present invention relates to a method of diagnosing a degeneration of the retina in a mammal or a predisposition thereto comprising assessing for the presence of prominin-1 on the surface of the particles of the invention in a body fluid from said mammal wherein the absence of said particles or a reduced amount of prominin-1 on the surface of said particles in comparison to a control is indicative of degeneration of the retina or a predisposition thereto.
机译:本发明涉及携带整合到膜prominin-1分子中的细胞外膜颗粒。根据本发明,这些颗粒也称为含prominin-1的膜颗粒。根据本发明的膜颗粒不同于外泌体。本发明的另一方面涉及诊断哺乳动物上皮癌或造血疾病的方法,其包括在所述哺乳动物的体液中评估本发明的细胞外膜颗粒的存在,其中所述细胞外膜水平降低。与对照值相比,这些颗粒指示上皮癌或造血系统疾病的存在。或者,所述颗粒水平的增加表明在哺乳动物中这种疾病的存在。另外,本发明涉及在哺乳动物中预后实体瘤的方法,其包括确定所述哺乳动物的体液中本发明的颗粒数目随时间的变化。最后,本发明涉及一种诊断哺乳动物视网膜变性或易感性的方法,该方法包括评估来自所述哺乳动物的体液中本发明的颗粒表面上是否存在prominin-1。与对照相比,所述颗粒的不存在或所述颗粒的表面上prominin-1的量减少,表明视网膜变性或其易感性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号